Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
New VC in Boston: Arch Venture Partners Opens Small Office With Eye Toward Basic Science, Multidisciplinary Collaborations
|
Robert Buderi |
09/21/09 |
Boston
|
|
New Constellation Pharma CEO Gives Expected Timeline for Epigenetics Firm’s Cancer Drug Research
|
Ryan McBride |
09/01/09 |
Boston
|
|
VMware Springs for SpringSource, Turbine Takes $6.7M, CombinatoRx Teams With Clinical Data, & More Boston-Area Deals News
|
Rebecca Zacks |
08/14/09 |
Boston
|
|
Constellation Pharma Hires New CEO, Collects Last $17M of its Series A Financing
|
Ryan McBride |
08/13/09 |
Boston
|
|
Edimer Pharmaceuticals Receives New Financing
|
VentureDeal |
06/30/09 |
Boston
|
|
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/10/09 |
Boston
|
|
Seventh Sense Biosystems Developing Tech Akin to Check-Engine Light for the Body
|
Ryan McBride |
06/05/09 |
Boston
|
|
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/28/09 |
Boston
|
|
Agios Lands Genentech Cancer Drug Leader as New CEO
|
Luke Timmerman |
05/27/09 |
Boston
|
|
Harvard Researcher to Helm Merck’s Cancer Research, Genzyme Acquires Certain Exact Sciences Assets, NeurAxon Out to Axe Migraines, & More Boston-Area Life Sciences
|
Rebecca Zacks |
02/04/09 |
Boston
|
|
Zafgen’s Big Idea: Fight Fat by Cutting Off Its Blood Supply
|
Luke Timmerman |
01/28/09 |
Boston
|
|
Hey Life Sciences Fans, Remember The Deals Back in 2008…
|
Ryan McBride |
01/05/09 |
Boston
|
|
A Totally Cool $45M for Konarka, a $24M Boost for Momenta, IPO Woes for TransMedics and BioTrove, & More Boston-Area Deals News
|
Rebecca Zacks |
12/19/08 |
Boston
|
|
Seventh Sense Biosystems Raises $4.75M Series A, Board Attracts MIT’s Langer and Other Big Names
|
Ryan McBride |
12/17/08 |
Boston
|
|
Seventh Sense Biosystems Inc Receives $4,180,000 Series A Financing Round
|
VentureDeal |
12/16/08 |
Boston
|
|
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/26/08 |
Boston
|
|
Agios Pharmaceuticals Forges Ahead With Lab to Starve Cancer Cells
|
Luke Timmerman |
11/24/08 |
Boston
|
|
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/20/08 |
Boston
|
|
Brightcove Bonds with Conde Nast, BSX Backs Brain-Implant Firm, $8 Million Shared With PeerApp, & More Boston-Area Deals News
|
Rebecca Zacks |
11/18/08 |
Boston
|
|
ZafGen Scores $14M Series B
|
Rebecca Zacks |
11/17/08 |
Boston
|
|
Zafgen, Inc. Lands $14,000,000 Series B Financing Round
|
VentureDeal |
11/17/08 |
Boston
|
|
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News
|
Rebecca Zacks |
11/05/08 |
Boston
|
|
Alnara Pharmaceuticals Aims to Make Biotech Drugs You Can Swallow, And That Go Right Where They Belong
|
Luke Timmerman |
10/30/08 |
Boston
|
|
Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round
|
VentureDeal |
10/30/08 |
Boston
|
|
Sirtris Settles in at GSK, Alnylam Raises IP Questions on Bio Bill, Targanta Takes on Cubist’s Market, & More Life Sciences News
|
Rebecca Zacks |
09/24/08 |
Boston
|
|
Third Rock Ventures Heads “Back to the Basics,” Nurtures Disruptive Life Sciences Companies
|
Luke Timmerman |
09/23/08 |
Boston
|
|
Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News
|
Rebecca Zacks |
09/10/08 |
Boston
|
|
Zafgen, Developer of Fat-Shrinking Drugs, Hires Novartis Scientist as New CEO and Emerges From Stealth Mode
|
Luke Timmerman |
09/09/08 |
Boston
|
|
GT Solar Sees Brighter IPO Skies; Pfizer, Merck, and Eli Lilly Back Boston Startup; GSI Group Beams out $360M for Excel Technology & More Deals News
|
Rebecca Zacks |
07/14/08 |
Boston
|
|
Boston Scientific Wins Stent Approval, Resolvyx Moves Closer to Fish-Oil Drug Trials, Codon Cuts Algae Fuel Deal, & More Life Sciences News
|
Rebecca Zacks |
07/09/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
